Clinical Trial Update: Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responders [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on adaptive nicotine substitution to maintain smoking reduction or abstinence in nicotine responders; the Rose Research Center, LL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence

Drugs mentioned

• Nicotine replacement therapy (nicotine replacement therapy)

Snippet

Sponsor: Rose Research Center, LLC | Conditions: Smoking Cessation, Harm Reduction | Phase 3 | Status: COMPLETED